Do Anti-Inflammatories Help Heal Pulled Muscles?

Anti-inflammatory drugs like ibuprofen and naproxen reduce pain and soreness after a pulled muscle, but they do not appear to help the muscle actually heal, and growing evidence suggests they may slow it down. A 2017 systematic review and meta-analysis found that NSAIDs reduce short-term strength loss, soreness, and markers of muscle damage in humans, yet laboratory and animal research consistently shows these same drugs interfere with the cellular machinery muscles need to rebuild. That conflict between feeling better and getting better is the central issue, and understanding it changes how you should think about reaching for the medicine cabinet after a strain.

Why Inflammation Is Not the Enemy After a Muscle Strain

When you pull a muscle, the fibers tear, usually at the junction where muscle meets tendon. That is where the greatest mechanical stress concentrates during the kind of lengthening contraction that causes most strains. Within hours, the damaged area fills with immune cells, fluid, and debris. By 24 hours, fiber breakdown is underway and inflammatory cells have infiltrated the injury site. By 48 hours, there is intense inflammatory cell activity and complete breakdown of the damaged fibers.¹ This looks and feels terrible, but it is the demolition phase that precedes reconstruction.

The immune cells that arrive first, neutrophils, clear away damaged tissue and set the stage for the next wave. Macrophages follow, and their role is not simply to continue the cleanup. They shift from a pro-inflammatory state to one that actively promotes repair, releasing growth factors that signal muscle stem cells to wake up and start rebuilding.² That transition from destruction to repair is tightly choreographed, and the inflammatory phase is the trigger for the regenerative one.³ When you suppress inflammation with a drug, you are not simply removing pain. You are muting the signal that tells the muscle to start rebuilding.

How NSAIDs Interfere with Muscle Stem Cells

Muscles regenerate through satellite cells, a population of stem cells that sit dormant along the surface of muscle fibers until injury activates them. Once activated, satellite cells multiply, mature, and fuse together to form new muscle fibers. NSAIDs work by blocking cyclooxygenase enzymes, and those same enzymes turn out to be involved at every stage of satellite cell activity. Blocking the COX-2 enzyme reduces satellite cell multiplication, and blocking both COX-1 and COX-2 together impairs differentiation and fusion as well.⁴

This is not just a test-tube finding. A human study infusing an NSAID directly into muscle during and after eccentric exercise found that the drug suppressed the expected increase in satellite cell numbers eight days later.⁵ Fewer active satellite cells means less raw material for the muscle to rebuild with. The practical worry is that this does not just slow things down temporarily but leads to a structurally inferior repair.

What Animal Studies Show About Tissue Quality

Animal experiments allow researchers to look at muscle tissue under a microscope weeks after injury, something you obviously cannot do in a human clinical trial. The findings here are concerning. In one study, mice given a COX-2-specific inhibitor after a muscle laceration showed delayed regeneration at early time points and ended up with increased fibrosis, meaning more scar tissue and less functional muscle.⁶ The drug-treated muscles had higher levels of a growth factor associated with scar formation.

A separate study using piroxicam in rabbits with experimentally induced strains found the same pattern: a delay in both the inflammatory response and muscle regeneration. By 11 days, both treated and untreated muscles had regenerated fibers bridging the injury site, but the treated group showed increased connective tissue scarring.⁷ The endpoint here matters: the muscle may close the gap either way, but if it fills it with scar tissue instead of contractile fibers, you end up with a weaker, stiffer muscle that is more vulnerable to reinjury.

The Short-Term Clinical Paradox

If NSAIDs impair healing, why do they seem to help in human trials? The answer is that most clinical studies measure things like pain, soreness, and short-term strength recovery, outcomes where NSAIDs perform reasonably well. A systematic review and meta-analysis covering human and animal data concluded that NSAIDs reduce strength loss, soreness, and blood markers of muscle damage after acute injury, at least in the short term.⁸ For topical NSAIDs applied to the skin, a large Cochrane review of acute pain found that about one in every four to five people treated got meaningful pain relief they would not have gotten from a placebo.⁹

But a review examining the broader picture noted that animal models show short-term benefits alongside long-term adverse effects on tissue structure and function.¹⁰ A separate analysis reached a similar conclusion: whatever early benefit NSAIDs provide appears not to be maintained over the long term, and may even be negated by a deficit in repair quality. At the cellular level, the evidence points to a negative influence on satellite cells as the likely mechanism.¹¹ The uncomfortable truth is that we have decent evidence NSAIDs help you feel and function better in the first few days, and separate evidence suggesting the muscle itself may pay a price you do not notice until much later.

Does Timing Change the Equation

One intuitive compromise is to use NSAIDs early, when pain is worst, and stop before the regenerative phase gets going. Some research supports this logic, but the window is tighter than you might expect. In rats, a single prophylactic dose or a two-day course started right after injury preserved short-term strength, but treatment delayed by three days had no measurable effect on strength at seven days.¹² In other words, if you wait too long, you miss both the pain-relief window and any potential benefit.

A cellular study looking at what happens when you give an NSAID about two days after injury found that by that point, the pro-inflammatory response had already peaked and the body had shifted into its repair phase. Giving the drug at that stage did not significantly change the immune cell profile in the tissue.¹³ This suggests that delayed use is largely irrelevant to inflammation, but it also means the drug is not doing anything useful at that point beyond dulling pain, which you could accomplish with a non-anti-inflammatory painkiller.

Acetaminophen as an Alternative for Pain

If much of the clinical benefit of NSAIDs comes from their painkilling effect rather than their anti-inflammatory action, then acetaminophen (paracetamol) deserves a second look. One study directly compared a COX-2-selective NSAID to acetaminophen for acute muscle injury and found their effects were similar. There were no differences in tissue weights or histological appearance of the injured muscle, leading the researchers to suggest that the anti-inflammatory properties of the NSAID were not an important feature of its clinical action.¹⁴ Acetaminophen relieves pain through a different mechanism that does not suppress cyclooxygenase activity in peripheral tissues the way NSAIDs do, so it may give you pain control without the same interference with satellite cells and tissue remodeling.

This is not a settled conclusion, and acetaminophen has its own dose-related liver toxicity to consider, but for someone specifically worried about muscle healing quality after a significant strain, it is a reasonable option to discuss with a clinician.

NSAIDs and Training Adaptations

The concern about anti-inflammatories and muscle extends beyond acute injuries. A study of young adults taking maximum over-the-counter doses of ibuprofen during eight weeks of resistance training found that the drug blunted both strength gains and muscle growth compared to a low-dose aspirin control group.¹⁵ This fits the satellite cell story: resistance training creates micro-damage that triggers the same inflammatory and regenerative cascade as a strain, just at a smaller scale. If you chronically suppress that process with high-dose NSAIDs, you get less adaptation over time.

For athletes and regular exercisers who pop ibuprofen routinely, this finding is worth paying attention to. The habit of using NSAIDs as a preventive measure or as a daily recovery aid appears to undermine the very adaptations training is supposed to produce.

The PEACE and LOVE Framework

Sports medicine has been gradually moving away from the old RICE protocol (rest, ice, compression, elevation) toward frameworks that respect the role of inflammation. The most recent version, known by the acronym PEACE and LOVE, explicitly recommends avoiding anti-inflammatory medications during the early healing phase. The reasoning is that inflammation plays a crucial role in tissue repair and should not be arbitrarily suppressed.¹⁶ The “A” in PEACE stands for “avoid anti-inflammatories,” which is a striking change from decades of standard advice.

Interestingly, even ice falls under scrutiny in this framework. A rat study found that icing applied soon after a crush injury delayed macrophage arrival, retarded satellite cell differentiation, and resulted in smaller muscle fibers and more collagen deposition weeks later compared to uniced muscles.¹⁷ The mechanism is similar to what NSAIDs do: by suppressing the early inflammatory response, you delay everything downstream. Ice remains useful for pain management and limiting excessive swelling in certain situations, but the old reflex of icing every soft tissue injury aggressively and continuously is falling out of favor among researchers who study tissue repair.

Early Movement Matters More Than Medication

If suppressing inflammation is counterproductive, what actually helps a pulled muscle heal? The strongest evidence points to controlled early movement. Research on mobilization timing found that starting gentle movement after a brief period of protection leads to better fiber alignment within the healing muscle, and the regenerating fibers orient themselves in the same direction as the surrounding healthy tissue.¹⁸ Muscles mobilized after a short immobilization period recovered strength and energy-absorbing capacity comparable to those treated with immediate mobilization. In contrast, prolonged immobilization is associated with disorganized repair and a weaker end result.

The practical takeaway is that the first few days after a strain warrant protection from activities that could extend the tear, but the transition to gentle, progressive loading should happen sooner than most people expect. A physical therapist can guide that progression, and the loading itself appears to do more for healing quality than any pill.

Corticosteroid Injections for Severe Strains

For severe muscle strains with a palpable defect within the muscle, some sports medicine physicians use corticosteroid injections to manage inflammation and speed return to activity. This practice has the most data in professional football. A 13-year study of hamstring injuries in the NFL found that among players with severe, discrete injuries treated with intramuscular corticosteroid and anesthetic injections, only about 16% missed any games, and final examinations showed no strength deficits or loss of muscle bulk.¹⁹ A broader study of both muscle strains and ligament sprains in the NFL reported no complications from the injections and described them as safe and effective for returning athletes to competition.²⁰

However, there are caveats worth noting. A systematic review on the myotoxicity of injections for acute muscle injuries found limited evidence that single corticosteroid injections are not harmful to muscle tissue on their own, but that they may have a synergistic toxic effect when combined with local anesthetics.²¹ Since corticosteroid injections for muscle strains are almost always combined with anesthetic in practice, that finding deserves attention. This is also a treatment used in elite athletes under close medical supervision with access to intensive rehabilitation, a context that does not translate directly to someone managing a hamstring pull at home.

Platelet-Rich Plasma and Other Biologics

Platelet-rich plasma (PRP) injections have attracted interest as a way to accelerate muscle healing by concentrating growth factors at the injury site rather than suppressing the inflammatory response. Basic science studies show that PRP increases the concentration of several growth factors involved in tissue repair and can increase leukocyte infiltration at the injection site.²² The biological rationale is appealing: instead of dampening the healing response, you amplify it.

Clinical results have been less convincing. A randomized, double-blind, placebo-controlled trial of PRP for muscle rupture with hematoma found that the PRP group recovered in about 32 days on average compared to about 38 days for the control group, a difference that was not statistically significant.²³ PRP remains a topic of active research, but as of now it has not proven itself in rigorous human trials for muscle strains.

Natural Anti-Inflammatory Supplements

Some people turn to food-derived compounds with anti-inflammatory properties, hoping to get pain relief without the downsides of pharmaceutical NSAIDs. Tart cherry juice is among the most studied options. A systematic review and meta-analysis found that tart cherry juice supplementation improved recovery of muscle strength after exercise-induced damage, with progressively larger effects over the days following exercise. It also reduced C-reactive protein, a blood marker of inflammation, in the first 48 hours after exercise.²⁴ However, it did not significantly reduce muscle soreness, and the studies included showed high variability in results.

Whether compounds like tart cherry anthocyanins interfere with satellite cell activity the way pharmaceutical NSAIDs do is not well established. Their anti-inflammatory mechanism is less potent and less targeted than COX inhibition, which may mean they modulate the response without shutting it down. But that is partly speculation. The honest assessment is that food-based anti-inflammatories are unlikely to cause the same degree of healing impairment as pharmaceutical NSAIDs, but the evidence base is thinner, and the strength recovery findings, while encouraging, come with enough statistical noise that strong conclusions are premature.

Side Effects Specific to Active People

Beyond the healing question, NSAIDs carry systemic risks that can be amplified by the physiological demands of exercise. Athletes face well-documented risks to the heart, gut, and kidneys from NSAID use, and the kidney risk is especially relevant because exercise combined with dehydration and concurrent illness can create a cumulative insult that a single factor alone might not produce.²⁵ Endurance athletes exercising in heat while taking NSAIDs are at particular risk for acute kidney injury, because the drug blocks the prostaglandins that help maintain blood flow to the kidneys during physiological stress. Gastrointestinal bleeding is another concern, as exercise itself can reduce blood flow to the gut, and adding an NSAID compounds the problem. These are not rare theoretical risks for people who are training through a muscle injury and taking NSAIDs daily to manage it.